Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




BioMicro Systems To Be Distribution Partner of Arrayjet

By Labmedica staff writers
Posted on 31 May 2007
Arrayjet (Mayfield, Scotland) has announced that it has appointed BioMicro Systems (Salt Lake City, UT, USA) as their exclusive distribution partner in the United States.

BioMicro Systems have been successful with their MicroArray User Interface (MAUI) hybridization system. More...
Michael Feldman Ph.D., CEO of the company believes that the combination of their MAUI system with the new small arrayer from Arrayjet will form a very effective system for potential users. The MAUI line of hybridization products include two high-performance models of the MAUI Hybridization system, the MAUI 4-Bay system, and the all-new MAUI 12-Bay system for automating the fluid processing of microarray samples in low-to-high-throughput laboratories.

Arrayjet has announced the release of the Sprint benchtop inkjet microarray spotter at the Advances in Microarray Technology (AMT) Conference in Edinburgh, UK, which was held on May 15-16, 2007. Designed for printing batches of slides in an R&D setting, Sprint has capacity for 20 microarray slides to be loaded and printed from two microtiter plates (96 or 384 well). Sample number may be increased by addition of two further microtiter plates during the printing run.

An extended range of substrate carriers will be available with Sprint, enabling printing onto non-glass slide substrates such as silicon wafers or glass-bottomed plates.

Dr. Feldman said, "The Arrayjet inkjet microarray spotters offer customers in the [United States] the latest technology that affords the most flexibility in printing arrays, providing excellent performance, throughput, and value. This combination of technologies gives scientists the tools to customize and optimize array design, hybridization performance, and data quality.”


Related Links:
Arrayjet
BioMicro Systems

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.